AC
Archer-Daniels-Midland Co (ADM)·Q4 2024 Earnings Summary
Executive Summary
- Q4 2024 GAAP EPS was $1.17, up 10% year over year, while adjusted EPS was $1.14, down 16%; revenue was $21.50B, down 6% YoY, and total segment operating profit declined 16% to $1,051M, reflecting weaker crush and biodiesel margins and policy uncertainty .
- Segment mix: Ag Services & Oilseeds fell 32% YoY to $644M; Carbohydrate Solutions rose 3% to $319M; Nutrition swung to an $88M profit from a $(10)M loss, aided by insurance recoveries and lapping prior nonrecurring headwinds .
- 2025 guidance: adjusted EPS $4.00–$4.75, corporate costs $1.7–$1.8B, CapEx $1.5–$1.7B, ETR 21–23%; soybean crush margins $45–$55/ton and canola $50–$70/ton; company targets $500–$750M cost savings over 3–5 years and plans a 600–700 role reduction in 2025 .
- Capital returns and catalysts: quarterly dividend raised 2% to $0.510, extended buyback program (100M shares); near-term stock narrative hinges on biofuel policy clarity (45Z), crush margin normalization in 2H 2025, and execution of cost-saving portfolio actions .
What Went Well and What Went Wrong
What Went Well
- Nutrition returned to profitability ($88M vs. $(10)M), driven by improved mix, lapping prior-year nonrecurring items, and $46M insurance proceeds; Animal Nutrition margins improved on cost optimization .
- Strong operational progress: reduced unplanned downtime in North American soy assets, improved crush volumes in December, near-full run rates at Spiritwood; double-digit growth areas in biosolutions and Health & Wellness .
- Cost discipline: announced targeted actions to deliver $500–$750M savings over 3–5 years, including $200–$300M in 2025 and 600–700 role reductions, emphasizing SG&A control and manufacturing efficiencies .
What Went Wrong
- Ag Services & Oilseeds (-32% YoY): lower crush execution margins on higher industry run rates, manufacturing costs, and biofuel/trade policy uncertainty; RPO margins compressed on increased pretreatment capacity and UCO imports .
- Carbohydrate Solutions faced softer EMEA margins and ethanol margin pressure despite robust export demand; ethanol EBITDA expected breakeven near term .
- Ongoing Decatur East headwinds and specialty ingredients inefficiencies weighed on Human Nutrition; higher insurance premiums and lower texturants pricing persisted .
Financial Results
Guidance Changes
Earnings Call Themes & Trends
Management Commentary
- “Today, ADM reported fourth quarter adjusted earnings per share of $1.14… Though 2024 presented a variety of challenges, our diligent focus on improving operations has netted positive impact across the network.” — Juan Luciano, CEO .
- “We anticipate cost actions to deliver in the range of $500 million to $750 million over the next 3 to 5 years with $200 million to $300 million in 2025.” — Juan Luciano .
- “We expect adjusted earnings per share to be between $4 to $4.75 per share [in 2025]… lower margins in AS&O and Carbsol to create a material headwind… cost out $200–$300 million.” — Monish Patolawala, CFO .
- “We expect soybean crush execution margins to range from $45 to $55 per tonne… and canola… $50 to $70 per tonne.” — Monish Patolawala .
Q&A Highlights
- Nutrition cadence: Q1 sequentially flat ex-$46M insurance; recovery expected after Decatur East restart (target Q2 2025) with Flavors/biotics strength and Animal Nutrition margin improvements .
- Vegetable oil demand and 45Z: soybean oil share seen rising from ~35% to ~40%; interim guidance constructive but final clarity pending; 2H 2025 carry suggests margin improvement .
- AS&O trajectory: very soft Q1 (down ~50% YoY), self-help and policy clarity set up for stronger 2H; no negative take-or-pay expected in Brazil vs 2024 .
- Tariffs: guidance excludes tariff impacts; ADM’s global origination/destination footprint provides optionality to re-route trade flows; monitor retaliation risks .
- Internal controls: continued remediation of material weakness with enhanced design, documentation, and training on intersegment sales; new CAO hired from Cargill .
Estimates Context
- Wall Street consensus (S&P Global) for Q4 2024 EPS and revenue was not retrievable due to SPGI daily rate limits at the time of this analysis; therefore, comparisons to consensus are unavailable. Values would normally be sourced from S&P Global; consensus data unavailable at time of request.
Key Takeaways for Investors
- Near-term pressure in AS&O and RPO from biofuel policy uncertainty and UCO imports should ease as 45Z guidance finalizes; management points to 2H margin recovery signals including board crush carry .
- 2025 framework is conservative with adjusted EPS $4.00–$4.75, reflecting weaker fundamentals offset by $200–$300M cost-out and operational improvements; watch execution on savings .
- Nutrition’s turnaround is progressing; expect flatter Q1 ex-insurance and a stronger H2 as Decatur East restarts and Flavors/biotics growth continues; specialty ingredients costs remain a watch item .
- Capital allocation remains shareholder-friendly (dividend increase, extended buyback program) while maintaining ~2x leverage; discipline in CapEx and portfolio simplification should support ROIC .
- Segment mix: Carbohydrate Solutions resilience (North America S&S strength) offers ballast amid AS&O volatility; ethanol margins breakeven near term but export demand supports volumes .
- Key catalysts: final 45Z guidance, tariff decisions (U.S./Canada/China), Argentina export tax evolution, and timing of insurance recoveries in 2025 .
- Risk factors: prolonged policy uncertainty, margin compression from elevated global crush, specialty ingredients inefficiencies, and higher legal/SG&A costs; offset by automation/digitization and portfolio actions .